The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Low-dose Naltrexone Targets the Opioid Growth Factor-Opioid Growth Factor Receptor Pathway to Inhibit Cell Proliferation: Mechanistic Evidence From a Tissue
Exp Biol Med (Maywood)
September 2011
https://pubmed.ncbi.nlm.nih.gov/21807817/
The Uses of Low-Dose Naltrexone in Clinical Practice
BMJ Case Reports
January 2018
https://www.researchgate.net/publication/328997819_Issue_4_The_Uses_of_Low-Dose_Naltrexone_in_Clinical_Practice
Off-label, Low-Dose Naltrexone for Refractory Chronic Low Back Pain
Pain Med
May 2014
https://europepmc.org/article/med/24967470
Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis
BMC Medicine
15 January 2019
https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-018-1242-0
Low-dose naltrexone inhibits the epithelial-mesenchymal transition of cervical cancer cells in vitro and effects indirectly on tumor-associated macrophages in vivo
Int Immunopharmacol
September 2020
https://pubmed.ncbi.nlm.nih.gov/32585612/
Dr. Armin Schwarzbach, Infections in Cancer and Autoimmune Disorders. Presented by Markus Berger.
Mark Mandel, PharmD - LDN and Pets (2017 Conference) (LDN, low dose naltrexone)
Albeit a brief ten minute presentation, Dr Mandel proves to demonstrate how Low Dose Naltrexone (LDN) can be effective in treating inflammatory conditions in not only humans but also dogs and other pets.
Dana Flavin, MD - Reversing Cancer with Biochemistry (2018 Conference) (LDN, low dose naltrexone)
Dr Dana Flavin shares her presentation on Reversing Cancer at the LDN 2018 Conference.
Akbar Khan, MD - Cancer Case Studies (2016 Conference) (LDN, low dose naltrexone)
In this presentation Dr Khan talks about many case studies involving Transitional cell carcinoma (TCC), colon cancer and Adenoid cystic carcinoma (ACC), explaining how Low Dose Naltrexone (LDN) can improve the lives of cancer patients.
Akbar Khan, MD - Cancer Therapy (2016 Conference) (LDN, low dose naltrexone)